Retatrutides Peptides
Retatrutide is an investigational peptide being studied for its potential role in weight management and metabolic health. Unlike medications that target a single pathway, retatrutide is designed to act on three important hormone receptors: GLP-1, GIP, and glucagon receptors.
Researchers are studying how this triple-action approach may influence appetite, food intake, body weight, and the way the body manages energy and blood sugar. Early clinical research has generated significant interest, particularly in the fields of obesity and metabolic disease.
Retatrutide is still under clinical investigation and has not yet been approved for general medical use. It should not be presented as an approved treatment or used without appropriate medical and regulatory oversight.
Showing 1–16 of 19 results
